Aggarwal Gaurav sold UNCY
August 25, 2025 · Form 4 insider transaction
Aggarwal Gaurav sold 3,199 shares of Unicycive Therapeutics, Inc. at $1000.00 per share, a transaction worth $3.20M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The shares of Series A-2 Prime Preferred Stock were issued on March 14, 2024 and do not have an expiration date.; Vivo Opportunity Fund Holdings, L.P. is the record holder of the securities. The Reporting Person is a managing member of Vivo Opportunity, LLC, which is the general partner of Vivo Opportunity Fund Holdings, L.P. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.